Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|
| ? | BAKER BROS. ADVISORS LP | 1.56M | $39.37M | - |
| CEO | | 340.0K | $8.58M | - |
| Other | | 250.0K | $6.31M | - |
| Other | BORGESON JOHN A. | 183.3K | $4.63M | - |
| ? | | 40.0K | $1.01M | - |
| ? | | 40.0K | $1.01M | - |
| ? | | 40.0K | $1.01M | - |
| ? | Levy Richard S | 40.0K | $1.01M | - |
| ? | Bancroft Charles A | 40.0K | $1.01M | - |
| ? | Dahiyat Bassil I | 40.0K | $1.01M | - |
Transactions
50 transactions · page 7
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|
| 2020-06-22 | EHRLICH JASON | See Remarks | Sale+OE | 4,158 | $61.34 | $255,033.00 | -3.1% | → |
| 2020-05-20 | EHRLICH JASON | See Remarks | Sale+OE | 6,950 | $60.72 | $421,988.53 | -6.4% | → |
| 2020-04-20 | EHRLICH JASON | See Remarks | Sale+OE | 6,950 | $54.12 | $376,114.68 | -4.8% | → |
| 2020-04-09 | EHRLICH JASON | See Remarks | Sale+OE | 2,200 | $48.56 | $106,830.38 | -2.2% | → |
| 2020-04-02 | Liang Hong | SVP, Discovery Medicine | Sell | 4,000 | $42.34 | $169,360.00 | -3.0% | → |
| 2020-03-26 | Liang Hong | SVP, Discovery Medicine | Sell | 4,000 | $47.78 | $191,112.03 | -1.0% | → |
| 2020-03-20 | Levy Richard S | Director | Buy | 1,000 | $44.33 | $44,330.00 | +400.0% | → |
| 2020-03-20 | EHRLICH JASON | See Remarks | Sale+OE | 6,950 | $45.00 | $312,762.30 | -3.8% | → |
| 2020-03-19 | Liang Hong | SVP, Discovery Medicine | Sell | 4,000 | $39.45 | $157,810.60 | -1.4% | → |
| 2020-03-18 | BAKER BROS. ADVISORS LP | Director, 10% Owner | Buy | 150,000 | $39.29 | $5,893,804.48 | +0.3% | → |
| 2020-02-26 | BAKER BROS. ADVISORS LP | Director, 10% Owner | Buy | 291,495 | $57.84 | $16,859,047.08 | +0.5% | → |